According to a study published in Neurology Open Access, avoiding smoking, managing high blood pressure, and preventing Type 2 diabetes can delay the onset of dementia by nearly 13 years. Researchers monitored more than 12,400 dementia-free participants starting at age 55 for an average of 26 years, tracking how cardiovascular risk factors influence cognitive decline and longevity.
Cardiovascular Risk Factors Shape Dementia-Free Survival Rates
Total cardiovascular burden serves as a primary determinant of how long an individual lives without cognitive impairment, according to the study. Participants who maintained all three health factors—no smoking, normal blood pressure, and no diabetes—lived an average of just over 30 dementia-free years from age 55. That outcome represents nearly 13 additional years free of the condition compared to peers who presented all three risk factors.
Data from the Neurology Open Access study outlines a clear step-down pattern:
- Zero risk factors: Just over 30 dementia-free years (nearly 13 years longer than those with three).
- One risk factor: An extra 26.3 dementia-free years.
- Two risk factors: An extra 21 dementia-free years.
- Three risk factors: Just over 17 dementia-free years.
Participants carrying all three hazards around age 56 faced a doubled risk of developing dementia and a fivefold increase in premature death from other causes. The study notes that vascular risk factors including diabetes, hypertension, and smoking are well-established contributors to overall dementia risk.
Demographic Variations in Dementia-Free Years
The research identified distinct demographic differences in cognitive longevity. Women lived longer without dementia than men by an average of one and a half years. Additionally, white participants recorded more dementia-free years than Black participants by just over three and a half years. Investigators emphasize that because these risk factors often emerge in midlife, early identification and management remain critical to altering neurodegenerative trajectories.
Did you know? Cardiovascular risk factors like high blood pressure and smoking frequently develop during midlife, exerting lasting effects on long-term neurodegenerative pathology, according to the Neurology Open Access study.
Emerging Diabetes Medications and Cognitive Health
Recent pharmaceutical interventions offer additional pathways for managing cognitive decline risks associated with metabolic disorders. Two major studies published in JAMA Neurology on April 7, 2025, evaluated GLP-1 receptor agonists—such as Ozempic and Wegovy—alongside SGLT2 inhibitors in patients with Type 2 diabetes. One investigation linked GLP-1 drugs to a 33 per cent reduction in dementia risk. Another demonstrated an even greater benefit from SGLT2 inhibitors, which cut risk by 43 per cent.
Further clinical developments target diagnosed populations. Health Canada approved lecanemab, marketed as Leqembi, on October 29, 2025. The treatment is specifically intended for adults who carry a clinical diagnosis of mild dementia due to Alzheimer’s disease.
Alcohol Consumption and Elevated Dementia Risk
Lifestyle choices beyond blood pressure and smoking also influence neurological outcomes. A study published on September 23, 2025, in BMJ Evidence-Based Medicine found that any amount of alcohol consumption can elevate the risk of dementia. The research indicates that tripling alcohol intake leads to a 15 per cent higher risk of developing the condition.
Frequently Asked Questions
How many years can I gain by avoiding smoking, diabetes, and high blood pressure?
According to the Neurology Open Access study, individuals who avoid all three risk factors live nearly 13 years longer without dementia compared to those who have all three.
Do diabetes medications reduce the risk of cognitive decline?
Yes. Two studies published in JAMA Neurology found that GLP-1 medications and SGLT2 inhibitors are linked to a lower risk of cognitive decline and dementia in patients with Type 2 diabetes, with risk reductions ranging from 33 to 43 per cent.
Does alcohol consumption affect dementia risk?
Research published in BMJ Evidence-Based Medicine indicates that any amount of alcohol consumption can increase the risk of dementia, with higher consumption levels corresponding to elevated risk percentages.
Stay informed on medical developments: Subscribe to our weekly health newsletter for the latest research, clinical updates, and medical news delivered every Sunday. Explore our health archive for more reports on neurology and preventative medicine.
Related reading